Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Approves BioForm’s Radiesse Dermal Filler For HIV, Cosmetic Indications

This article was originally published in The Gray Sheet

Executive Summary

BioForm says it will likely go public within the next year following approval of its Radiesse dermal filler for the cosmetic treatment of nasolabial folds and facial wasting in patients with HIV

You may also be interested in...



Merz Pharma Gains Radiesse Dermal Filler Via $253 Mil. BioForm Acquisition

Merz Pharma Group will round out its aesthetic product offerings by adding the Radiesse wrinkle filler device through its $253 million acquisition of BioForm Medical, announced Jan. 4

Merz Pharma Gains Radiesse Dermal Filler Via $253 Mil. BioForm Acquisition

Merz Pharma Group will round out its aesthetic product offerings by adding the Radiesse wrinkle filler device through its $253 million acquisition of BioForm Medical, announced Jan. 4

Facial Wasting Fillers: CMS Considers Question Of Coverage Qualification

CMS says it is deciding whether reconstructive treatments for facial lipodystrophy syndrome, associated with human immunodeficiency virus medicines, can qualify for Medicare coverage under a statute that excludes cosmetic surgery from the federal program

Related Content

UsernamePublicRestriction

Register

LL1134478

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel